The promising medical qualities of psychedelics, such as LSD and psilocybin “magic” mushrooms, have been under-researched for decades owing to prevalent misconceptions about the safety and efficacy of these currently illegal drugs.
In this webinar summary we take stock of the current psychedelic innovation landscape and the vast potential for psychedelic treatments in healthcare. We also take a look at the conditions that Beckley Psytech and other prominent research organizations hope to address with psychedelic therapeutics.
This webinar summary covers:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
© 2021 Technology Networks
All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy